Lannett Seeking Fast Run Through $600M Reorg
Counsel for generic-drug maker Lannett told a Delaware bankruptcy judge on Thursday that the company is hoping to get approval for its Chapter 11 plan to cut $600 million in debt...To view the full article, register now.
Already a subscriber? Click here to view full article